
Stablecoin Development Corp. (AMEX: SDEV) Stock Competitors & Peer Comparison
See SDEV's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SDEV and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SDEV | $1.02 | -0.97% | 27.6M | -0.18 | -$5.73 | +390.24% |
| RPRX | $57.97 | +2.11% | 25.7B | 11.04 | $5.25 | +1.58% |
| CORT | $114.23 | +3.12% | 12.3B | 326.37 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $91.03 | +0.90% | 8.1B | 650.21 | $0.14 | N/A |
| KNSA | $76.53 | +0.62% | 5.8B | 85.03 | $0.90 | N/A |
| TRLV | $9.08 | +3.77% | 1.5B | -21.50 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $18.56 | +1.70% | 1.1B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
SDEV vs RPRX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, RPRX has a market cap of 25.7B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while RPRX trades at $57.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas RPRX's P/E ratio is 11.04. In terms of profitability, SDEV's ROE is +7.90%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, SDEV is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
SDEV vs CORT Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, CORT has a market cap of 12.3B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while CORT trades at $114.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas CORT's P/E ratio is 326.37. In terms of profitability, SDEV's ROE is +7.90%, compared to CORT's ROE of +0.08%. Regarding short-term risk, SDEV is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
SDEV vs WBA Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas WBA's P/E ratio is -1.64. In terms of profitability, SDEV's ROE is +7.90%, compared to WBA's ROE of -0.42%. Regarding short-term risk, SDEV is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
SDEV vs LQDA Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, LQDA has a market cap of 8.1B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while LQDA trades at $91.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas LQDA's P/E ratio is 650.21. In terms of profitability, SDEV's ROE is +7.90%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, SDEV is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
SDEV vs KNSA Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, KNSA has a market cap of 5.8B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while KNSA trades at $76.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas KNSA's P/E ratio is 85.03. In terms of profitability, SDEV's ROE is +7.90%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, SDEV is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
SDEV vs TRLV Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while TRLV trades at $9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas TRLV's P/E ratio is -21.50. In terms of profitability, SDEV's ROE is +7.90%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, SDEV is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
SDEV vs HROWL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas HROWL's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, SDEV is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
SDEV vs HROWM Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas HROWM's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, SDEV is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
SDEV vs LTGO Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, LTGO has a market cap of 1.1B. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while LTGO trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas LTGO's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to LTGO's ROE of N/A. Regarding short-term risk, SDEV is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check LTGO's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
SDEV vs CUVL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, CUVL has a market cap of 339.9M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while CUVL trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas CUVL's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to CUVL's ROE of N/A. Regarding short-term risk, SDEV is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
SDEV vs LFMD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, LFMD has a market cap of 175.1M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while LFMD trades at $3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas LFMD's P/E ratio is -7.24. In terms of profitability, SDEV's ROE is +7.90%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, SDEV is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
SDEV vs LFMDP Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while LFMDP trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, SDEV's ROE is +7.90%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, SDEV is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
SDEV vs CIRC Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, CIRC has a market cap of 63M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while CIRC trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas CIRC's P/E ratio is -1.59. In terms of profitability, SDEV's ROE is +7.90%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, SDEV is less volatile compared to CIRC. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check CIRC's competition here
Rite Aid Corporation (NYSE: RAD)
SDEV vs RAD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas RAD's P/E ratio is -0.05. In terms of profitability, SDEV's ROE is +7.90%, compared to RAD's ROE of +2.76%. Regarding short-term risk, SDEV is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
SDEV vs GLTO Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas GLTO's P/E ratio is -1.78. In terms of profitability, SDEV's ROE is +7.90%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, SDEV is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
SDEV vs SCYX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, SCYX has a market cap of 32.4M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while SCYX trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas SCYX's P/E ratio is -1.51. In terms of profitability, SDEV's ROE is +7.90%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, SDEV is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
SDEV vs NSRX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, NSRX has a market cap of 29.4M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while NSRX trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas NSRX's P/E ratio is -4.74. In terms of profitability, SDEV's ROE is +7.90%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, SDEV is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check NSRX's competition here
Cerenome, Inc. (NASDAQ: CNSY)
SDEV vs CNSY Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, CNSY has a market cap of 26.4M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while CNSY trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas CNSY's P/E ratio is -0.53. In terms of profitability, SDEV's ROE is +7.90%, compared to CNSY's ROE of N/A. Regarding short-term risk, SDEV is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
SDEV vs BFRI Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, BFRI has a market cap of 15.5M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while BFRI trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas BFRI's P/E ratio is -1.13. In terms of profitability, SDEV's ROE is +7.90%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, SDEV is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
SDEV vs CJJD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas CJJD's P/E ratio is -0.46. In terms of profitability, SDEV's ROE is +7.90%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, SDEV is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
SDEV vs SSY Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas SSY's P/E ratio is -2.86. In terms of profitability, SDEV's ROE is +7.90%, compared to SSY's ROE of -0.09%. Regarding short-term risk, SDEV is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
SDEV vs POM Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, POM has a market cap of 7.3M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while POM trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas POM's P/E ratio is -0.21. In terms of profitability, SDEV's ROE is +7.90%, compared to POM's ROE of +0.16%. Regarding short-term risk, SDEV is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
SDEV vs PAVS Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, PAVS has a market cap of 6.4M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while PAVS trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas PAVS's P/E ratio is -0.08. In terms of profitability, SDEV's ROE is +7.90%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, SDEV is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
SDEV vs HKPD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, HKPD has a market cap of 4.6M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while HKPD trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas HKPD's P/E ratio is -6.99. In terms of profitability, SDEV's ROE is +7.90%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, SDEV is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check HKPD's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
SDEV vs AIXC Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, AIXC has a market cap of 4.1M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while AIXC trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas AIXC's P/E ratio is -0.09. In terms of profitability, SDEV's ROE is +7.90%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, SDEV is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check AIXC's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
SDEV vs MDVL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas MDVL's P/E ratio is -0.05. In terms of profitability, SDEV's ROE is +7.90%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, SDEV is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
SDEV vs ATNFW Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas ATNFW's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, SDEV is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
SDEV vs BGMSP Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, SDEV's ROE is +7.90%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, SDEV is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check BGMSP's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
SDEV vs BGMS Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas BGMS's P/E ratio is -0.25. In terms of profitability, SDEV's ROE is +7.90%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, SDEV is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check BGMS's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
SDEV vs AZNH Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas AZNH's P/E ratio is 38.35. In terms of profitability, SDEV's ROE is +7.90%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, SDEV is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
SDEV vs LFLYW Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, SDEV's ROE is +7.90%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, SDEV is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
SDEV vs SBFMW Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, SBFMW has a market cap of 175.2K. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while SBFMW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas SBFMW's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to SBFMW's ROE of -0.26%. Regarding short-term risk, SDEV is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check SBFMW's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
SDEV vs ESRX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas ESRX's P/E ratio is 10.69. In terms of profitability, SDEV's ROE is +7.90%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, SDEV is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check ESRX's competition here
POZEN Inc. (NASDAQ: POZN)
SDEV vs POZN Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, POZN has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas POZN's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to POZN's ROE of +0.61%. Regarding short-term risk, SDEV is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check POZN's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
SDEV vs OREX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, OREX has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas OREX's P/E ratio is -0.14. In terms of profitability, SDEV's ROE is +7.90%, compared to OREX's ROE of -0.54%. Regarding short-term risk, SDEV is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check OREX's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
SDEV vs CPD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, CPD has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas CPD's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to CPD's ROE of N/A. Regarding short-term risk, SDEV is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CPD's competition here
Shire plc (NASDAQ: SHPG)
SDEV vs SHPG Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas SHPG's P/E ratio is 11.35. In terms of profitability, SDEV's ROE is +7.90%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, SDEV is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check SHPG's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
SDEV vs IPXL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 27.6M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.02 on the AMEX, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.18, whereas IPXL's P/E ratio is -10.11. In terms of profitability, SDEV's ROE is +7.90%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, SDEV is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check IPXL's competition here